Our guess is that you havent tried this one
International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
We ranked each supplier on the signals that actually protect a research buyer: independent purity testing, batch paperwork, product form, shipping, and how openly the company explains what it sells
NDC: 70069-0172-10
Your dosage, route, cycle length, and monitoring needs depend on your health history, current medications, symptoms, injury type, recovery goals, and overall risk profile
These categories matter in compliance: These go through Phases I-III clinical trials, get reviewed, and are approved for specific indications and doses